The Psilocybin Dose Too Small to Trip
A viral claim says microdoses of psilocybin reverse obesity and diabetes. Here’s what the actual mouse study found — and the liver mechanism behind it.
Psilocybin, ketamine, MDMA and related research, explained.
A viral claim says microdoses of psilocybin reverse obesity and diabetes. Here’s what the actual mouse study found — and the liver mechanism behind it.
The science of psilocybin microdosing unpacked: brain rewiring, mood, focus, and the gap between hype and hard evidence in older adults.
Discover the key difference between meditation and hypnosis, which may suggest a distinct impact on higher-order awareness and brain function
Explore what a meta‐analysis of six trials says about psilocybin therapy for depression—benefits, side‐effects, and the limits of current evidence.
Explore emerging evidence on ibogaine therapy for opioid cravings, PTSD, and depression. Learn about early study outcomes, safety concerns, and limits of the research.
A deep dive into the emerging review on psychedelics for autism—what the data say, why neuroplasticity matters, and the ethical roadblocks ahead.
A 2026 preprint reviews 25 disciplines of altered states, from meditation to psychedelics, and maps the brain mechanisms behind mind‐expanding practices.
Psychedelic therapy may suggest new options for patients with treatment-resistant depression or PTSD, but what does the evidence show about its effectiveness…
A deep dive into the latest ADHD roadmap—how dopamine, genetics and brain imaging could finally give the disorder an objective test.
Explore the latest preprint review on altered states of consciousness, its neurobiological mechanisms, and emerging therapies like MDMA, psilocybin, and Life Between Lives hypnotherapy.